Comparative effectiveness in centesimal and 50 millesimal potencies of individualized homoeopathic medicine prescribed for treatment of patients with hyperuricemia-an open label prospective, randomised controlled trial
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 72
- 试验地点
- 1
研究概览
简要总结
This study aims to compare the effectiveness of individualized homoeopathic medicines prepared in two different potencies Centesimal and 50 millesimal in patients with hyperuricemia . Patient aged 18 to 65 years with raised serum uric acid level and symptoms such as joint pain or swelling will receive individualized homoeopathic medicines for the duration of 4 months period .The primary outcome will be the change in blood uric acid levels. Secondary measures include improvement in self reported health MYMOP2 score assessment and causal relation of improvement through MONARCH score and monitoring for any adverse drug reactions. The study will help to determine which potency scale offers better clinical benefit. No new medicine will be trailed. All the medicines will be administered orally. All the medicines will be procured from the GMP certified company. Potency, dose and repetition will be as per the principles of homoeopathy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •1 Serum uric acid levels more than 7.0 mg per dL in males and more than 6.0 mg per dL in females 2 Symptomatic Hyperuricemia like joint pain swelling restricted mobility 3 Patient who can understand either English or Bengali or Hindi languages 4 Willing to Provide written Informed Consent.
排除标准
- •1 Patients suffering from uncontrolled systemic illnesses or life threatening illnesses 2 Complicated cases of Hyperuricemia like gout, tophi deposits, uric acid stone, chronic kidney disease 3 Pregnant or lactating women 4 Any substance abuse 5 Patients on any kind of medication for hyperuricemia 6 Unstable psychiatric illnesses.
研究者
Dr Shikha Dubey
National Institute Of Homoeopathy